Curative Potential of GM-CSF-Secreting Tumor Cell Vaccines on Established Orthotopic Liver Tumors: Mechanisms for the Superior Antitumor Activity of Live Tumor Cell Vaccines

Journal of Biomedical Science

Volumn 11, Issue 2, 2004, Pages 228-238

  Tai, Kuo Feng ^a   Chen, Ding Shinn ^a   Hwang, Lih Hwa ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Granulocyte macrophage colony stimulating factor (GM CSF); Irradiated vaccine; Live vaccine; Orthotopic liver tumor; Tumor cell vaccine

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIVE VACCINE; TUMOR CELL VACCINE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; IMMUNE RESPONSE; IN VIVO STUDY; IRRADIATION; LIVER TUMOR; LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR CELL; TUMOR REGRESSION;

ANIMALS; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CELL TRANSPLANTATION; CYTOTOXICITY TESTS, IMMUNOLOGIC; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; KILLER CELLS, NATURAL; LIVER NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED F344; T-LYMPHOCYTES, CYTOTOXIC; TREATMENT OUTCOME;

ANIMALIA;

EID: 1442328755     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1159/000076035     Document Type: Article

References (53)

1. Allione A, Consalvo M, Nanni P, Lollini PL, Cavallo F, Giovarelli M, Forni M, Gulino A, Colombo MP, Dellabona P, et al. Immunizing and curative potential of replicating and non-replicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants. Cancer Res 54: 6022-6026;1994.
2. Armstrong CA, Botella R, Galloway TH, Murray N, Kramp JM, Song IS, Ansel JC. Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells. Cancer Res 56:2191-2198;1996.
3. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 392:245-252;1998.
4. Barajas M, Mazzolini G, Genove G, Bilbao R, Narvaiza I, Schmitz V, Sangro B, Melero I, Qian C, Prieto J. Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12. Hepatology 33:52-61;2001.
5. Cao G, Kuriyama S, Du P, Sakamoto T, Kong X, Masui K, Qi Z. Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor alpha gene transfer. Gastroenterology 112:501-510;1997.
6. Chen BM, Cheng TL, Tzou SC, Roffler SR. Potentiation of antitumor immunity by antibody-directed enzyme prodrug therapy. Int J Cancer 94:850-858;2001.
7. Chen CH, Chen DS. Hepatocellular carcinoma: 30 years' experience in Taiwan. J Formos Med Assoc 91:S187-202;1992.
8. Cohen PJ, Cohen PA, Rosenberg SA, Katz SI, Mule JJ. Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells. Eur J Immunol 24:315-319;1994.
9. Coleman WB, Wennerberg AE, Smith GJ, Grisham JW. Regulation of the differentiation of diploid and some aneuploid rat liver epithelial (stemlike) cells by the hepatic microenvironment. Am J Pathol 142:1373-1382;1993.
10. Colombo M. Hepatocellular carcinoma. J Hepatol 15:225-236;1992.
11. Colombo MP, Forni G. Cytokine gene transfer in tumor inhibition and tumor therapy: Where are we now? Immunol Today 15:48-51;1994.
12. Crispe IN, Mehal WZ. Strange brew: T cells in the liver. Immunol Today 17:522-525;1996.
13. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539-3543;1993.
14. Dranoff G, Mulligan RC. Gene transfer as cancer therapy. Adv Immunol 58:417-454;1995.
15. Drozdzik M, Qian C, Xie X, Peng D, Bilbao R, Mazzolini G, Prieto J. Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma. J Hepatol 32:279-286;2000.
16. Falkson G, Cnaan A, Schutt AJ, Ryan LM, Falkson HC. Prognostic factors for survival in hepatocellular carcinoma. Cancer Res 48:7314-7318;1988.
17. Farmer DG, Busuttil RW. The role of multimodal therapy in the treatment of hepatocellular carcinoma. Cancer 73:2669-2670;1994.
18. Fong L, Engleman EG. Dendritic cells in cancer immunotherapy. Annu Rev Immunol 18:245-273;2000.
19. Grabbe S, Bruvers S, Gallo RL, Knisely TL, Nazareno R, Granstein RD. Tumor antigen presentation by murine epidermal cells. J Immunol 146:3656-3661;1991.
20. Harshyne LA, Watkins SC, Gambotto A, Barratt-Boyes SM. Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J Immunol 166:3717-3723;2001.
21. He P, Tang ZY, Ye SL, Liu BB, Liu YK. The targeted expression of interleukin-2 in human hepatocellular carcinoma cells. J Exp Clin Cancer Res 19:183-187;2000.
22. Holmes KL, Palaszynski E, Fredrickson TN, Morse HC 3rd, Ihle JN. Correlation of cell-surface phenotype with the establishment of interleukin 3-dependent cell lines from wild-mouse murine leukemia virus-induced neoplasms. Proc Natl Acad Sci USA 82:6687-6691;1985.
23. Hsieh CL, Chen BF, Wang CC, Liu HH, Chen DS, Hwang LH. Improved gene expression by a modified bicistronic retroviral vector. Biochem Biophys Res Commun 214:910-917;1995.
24. Hsieh CL, Pang VF, Chen DS, Hwang LH. Regression of established mouse leukemia by GM-CSF-transduced tumor vaccine: Implications for cytotoxic T lymphocyte responses and tumor burdens. Hum Gene Ther 8:1843-1854;1997.
25. Huang L, Soldevila G, Leeker M, Flavell R, Crispe IN. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1:741-749;1994.
26. Kamada N, Brons G, Davies HS. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation 29:429-431;1980.
27. Katsanis E, Bausero MA, Panoskaltsis-Mortari A, Dancisak BB, Xu Z, Orchard PJ, Davis CG, Blazar BR. Irradiation of singly and doubly transduced murine neuroblastoma cells expressing B7-1 and producing interferon-gamma reduces their capacity to induce systemic immunity. Cancer Gene Ther 3:75-82;1996.
28. Levin B, Amos C. Therapy of unresectable hepatocellular carcinoma. N Engl J Med 332:1294-1296;1995.
29. Lin TM, Tsu WT, Chen CJ. Mortality of hepatoma and cirrhosis of liver in Taiwan. Br J Cancer 54:969-976;1986.
30. Liu ZX, Govindarajan S, Okamoto S, Dennert G. Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver. J Immunol 166:3035-3041;2001.
31. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, Pompili M, Brunello F, Lazzaroni S, Torzilli G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection. Radiology 197:101-108;1995.
32. Maass G, Schmidt W, Berger M, Schilcher F, Koszik F, Schneeberger A, Stingl G, Birnstiel ML, Schweighoffer T. Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: Three consecutive stages may be required for successful tumor vaccination. Proc Natl Acad Sci USA 92:5540-5544;1995.
33. Mach N, Dranoff G. Cytokine-secreting tumor cell vaccines. Curr Opin Immunol 12:571-575;2000.
34. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693-699;1996.
35. McCullough KD, Coleman WB, Smith GJ, Grishan JW. Age-dependent regulation of the tumorigenic potential of neoplastically transformed rat liver epithelial cells by the liver microenvironment. Cancer Res 54:3668-3671;1994.
36. Mehal WZ, Juedes AE, Crispe IN. Selective retention of activated CD8+ T cells by the normal liver. J Immunol 163:3202-3210;1999.
37. Musiani P, Modesti A, Giovarelli M, Cavallo F, Colombo MP, Lollini PL, Forni G. Cytokines, tumour-cell death and immunogenicity: A question of choice. Immunol Today 18:32-36;1997.
38. Nasu Y, Bangma CH, Hull GW, Lee HM, Hu J, Wang J, McCurdy MA, Shimura S, Yang G, Timme TL, Thompson TC. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: Suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model. Gene Ther 6:338-349;1999.
39. O'Farrelly C, Crispe IN. Prometheus through the looking glass: Reflections on the hepatic immune system. Immunol Today 20:394-398;1999.
40. Parmiani G, Colombo MP, Melani C, Arienti F. Cytokine gene transduction in the immunotherapy of cancer. Adv Pharmacol 40:259-307;1997.
41. Pelletier G, Ducreux M, Gay F, Luboinski M, Hagege H, Dao T, Van Steenbergen W, Buffet C, Rougier P, Adler M, Pignon JP, Roche A. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial. Groupe CHC. J Hepatol 29:129-134;1998.
42. Pham-Nguyen KB, Yang W, Saxena R, Thung SN, Woo SL, Chen SH. Role of NK and T cells in IL-12-induced anti-tumor response against hepatic colon carcinoma. Int J Cancer 81:813-819;1999.
43. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: Tolerance and donor cell chimerism. Hepatology 19:916-924;1994.
44. Rossi I, Nicoletti G, Landuzzi L, Frabetti F, De Giovanni C, Nanni P, Musiani P, Ferrantini M, Belardelli F, Lollini PL. Inhibition of lung colonisation of a mouse mammary carcinoma by therapeutic vaccination with interferon-alpha gene-transduced tumor cells. Clin Exp Metastasis 16:123-128;1998.
45. Saito S, Bannerji R, Gansbacher B, Rosenthal FM, Romanenko P, Heston WD, Fair WR, Gilboa E. Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines. Cancer Res 54:3516-3520;1994.
46. Schmidt-Wolf GD, Schmidt-Wolf IG. Cytokines and gene therapy. Immunol Today 16:173-175;1995.
47. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Yamamoto J, Shimada K, Kosuge T, Okada S, Takayasu K, Yamasaki S. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 28:1241-1246;1998.
48. Tao MH, Levy R. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 362:755-758;1993.
49. Tazi A, Bouchonnet F, Grandsaigne M, Boumsell L, Hance AJ, Soler P. Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J Clin Invest 91:566-576;1993.
50. Townsend SE, Su FW, Atherton JM, Allison JP. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Cancer Res 54:6477-6483;1994.
51. Tsao MS, Grisham JW, Nelson KG. Clonal analysis of tumorigenicity and paratumorigenic phenotypes in rat liver epithelial cells chemically transformed in vitro. Cancer Res 45:5139-5144;1985.
52. Venook AP. Treatment of hepatocellular carcinoma: Too many options? J Clin Oncol 12:1323-1334;1994.
53. Yamashita YI, Shimada M, Hasegawa H, Minagawa R, Rikimaru T, Hamatsu T, Tanaka S, Shirabe K, Miyazaki JI, Sugimachi K. Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model. Cancer Res 61:1005-1012;2001.